CN Stock MarketDetailed Quotes

002900 Harbin Medisan Pharmaceutical

Watchlist
  • 10.28
  • -0.24-2.28%
Market Closed May 10 15:00 CST
3.25BMarket Cap61.19P/E (TTM)

Harbin Medisan Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-27.86%246.82M
15.40%1.19B
21.08%922.46M
26.25%637.23M
33.29%342.15M
8.73%1.03B
7.66%761.89M
6.52%504.74M
11.52%256.69M
-29.36%945.8M
Operating revenue
-27.86%246.82M
15.40%1.19B
21.08%922.46M
26.25%637.23M
33.29%342.15M
8.73%1.03B
7.66%761.89M
6.52%504.74M
11.52%256.69M
-29.36%945.8M
Other operating revenue
----
68.22%34.09M
----
77.35%17.57M
----
-42.77%20.27M
----
-16.65%9.91M
----
518.91%35.41M
Total operating cost
-24.72%246.97M
13.15%1.2B
17.08%919.24M
21.84%627.69M
24.67%328.06M
-3.18%1.06B
3.17%785.11M
0.93%515.17M
8.34%263.15M
-19.09%1.09B
Operating cost
-16.82%105.98M
30.31%476.38M
29.77%347.21M
19.70%222.49M
21.96%127.41M
18.16%365.57M
17.36%267.56M
16.69%185.88M
25.44%104.47M
-37.03%309.38M
Operating tax surcharges
-30.70%3.03M
-6.05%14.71M
-1.63%11.74M
4.26%8.33M
8.79%4.38M
8.52%15.66M
9.82%11.94M
9.79%7.99M
7.53%4.02M
-12.68%14.43M
Operating expense
-44.01%80.76M
-7.07%421.8M
2.14%361.87M
16.56%266.59M
29.84%144.23M
-12.30%453.91M
0.66%354.29M
-0.72%228.72M
5.78%111.09M
-14.46%517.57M
Administration expense
14.61%39.16M
25.35%176.36M
34.71%124.78M
39.70%82.19M
20.32%34.17M
-5.91%140.69M
-4.52%92.62M
-6.65%58.83M
2.49%28.4M
15.66%149.53M
Financial expense
-182.51%-6.66M
36.81%-3.98M
14.46%-4.12M
-5.43%-3.78M
-197.64%-2.36M
-324.93%-6.29M
-294.76%-4.81M
-281.71%-3.59M
-177.21%-791.9K
208.09%2.8M
-Interest expense (Financial expense)
22.63%6.95M
1.29%22.89M
1.80%16.99M
6.82%11.22M
36.96%5.66M
63.72%22.6M
109.80%16.69M
93.19%10.5M
75.74%4.14M
48.00%13.8M
-Interest Income (Financial expense)
-24.56%-9.25M
4.86%-26.91M
-0.89%-20.76M
-9.93%-14.27M
-40.73%-7.43M
-156.56%-28.29M
-296.69%-20.58M
-336.80%-12.98M
-272.75%-5.28M
-110.42%-11.03M
Research and development
22.06%24.69M
26.37%112.81M
22.44%77.76M
38.94%51.87M
26.71%20.23M
-10.66%89.27M
-10.18%63.5M
-22.98%37.33M
-27.84%15.96M
-10.80%99.92M
Credit Impairment Loss
-108.68%-14.17K
490.27%2.78M
14.75%848.74K
142.46%310.17K
136.26%163.18K
48.20%-712.57K
220.47%739.64K
-27.42%-730.58K
68.60%-450.04K
66.13%-1.38M
Asset Impairment Loss
-113.74%-318.31K
-84.22%826.15K
-81.71%1.03M
-133.72%-1.08M
-105.22%-148.92K
137.72%5.23M
421.57%5.61M
293.38%3.2M
283.72%2.85M
-9,709.84%-13.88M
Other net revenue
-34.74%19.06M
27.16%90.31M
21.38%59.52M
37.65%46.94M
682.83%29.21M
-88.22%71.02M
-91.88%49.04M
-94.63%34.1M
-99.35%3.73M
1,155.99%602.64M
Fair value change income
-48.43%3.68M
-3.63%13.37M
269.83%10.03M
72.60%12.58M
175.90%7.15M
162.90%13.87M
-177.18%-5.91M
-86.15%7.29M
-224.84%-9.41M
115.78%5.28M
Invest income
-25.78%8.02M
-5.07%43.62M
-6.04%34M
23.14%24.64M
11.82%10.8M
-92.32%45.96M
-93.85%36.19M
-96.54%20.01M
-98.30%9.66M
4,398.23%598.32M
-Including: Investment income associates
-16.28%6.83M
-15.47%35.81M
-19.67%26.22M
-0.26%17.68M
5.43%8.15M
41.26%42.36M
58.27%32.65M
52.28%17.72M
516.58%7.73M
754.39%29.99M
Asset deal income
237.99%172.32K
80.42%-2.61M
-352.45%-2.6M
-662.72%-2.57M
56.26%-124.88K
-592.94%-13.31M
-220.59%-575.62K
38.49%-337.59K
-380.05%-285.48K
56.01%-1.92M
Other revenue
-33.86%7.52M
61.79%32.31M
24.86%16.21M
179.43%13.06M
730.23%11.38M
23.17%19.97M
88.77%12.99M
-4.64%4.67M
-62.97%1.37M
-78.78%16.21M
Operating profit
-56.32%18.91M
94.50%79.02M
143.02%62.74M
138.58%56.47M
1,689.38%43.3M
-91.07%40.63M
-95.31%25.82M
-96.05%23.67M
-100.48%-2.72M
1,189.70%454.81M
Add:Non operating Income
544.71%215.49K
13.57%2.9M
-43.55%1.39M
148.42%1.38M
-93.26%33.42K
230.40%2.55M
3,323.67%2.46M
1,009.76%556.39K
2,666.98%495.65K
178.72%772.25K
Less:Non operating expense
--74.01
-82.48%545.16K
-54.47%543.72K
2,979.20%480.97K
----
14.30%3.11M
149.08%1.19M
32.59%15.62K
-68.17%3.75K
14.16%2.72M
Total profit
-55.85%19.13M
103.08%81.37M
134.77%63.59M
136.97%57.37M
2,041.09%43.33M
-91.15%40.07M
-95.07%27.08M
-95.96%24.21M
-100.40%-2.23M
1,265.79%452.86M
Less:Income tax cost
-65.95%1.72M
-16.76%11.3M
-27.69%6.13M
27.20%6.94M
1,320.41%5.04M
-86.85%13.57M
-21.49%8.47M
-57.96%5.46M
-141.70%-412.97K
1,481.54%103.18M
Net profit
-54.52%17.41M
164.45%70.08M
208.73%57.46M
168.92%50.43M
FLtoP38.29M
-92.42%26.5M
-96.55%18.61M
-96.80%18.75M
SL-1.82M
1,212.94%349.68M
Net profit from continuing operation
-54.52%17.41M
164.45%70.08M
208.73%57.46M
168.92%50.43M
2,204.66%38.29M
-92.42%26.5M
-96.55%18.61M
-96.80%18.75M
-100.32%-1.82M
1,212.94%349.68M
Less:Minority Profit
-58.03%-1.38M
3.33%-3.58M
2.24%-2.66M
-0.33%-1.76M
-34.12%-870.29K
-191.14%-3.71M
-282.72%-2.73M
-365.73%-1.75M
-1,052.44%-648.9K
52.69%-1.27M
Net profit of parent company owners
-52.02%18.79M
143.86%73.66M
181.78%60.12M
154.50%52.19M
3,445.73%39.16M
-91.39%30.21M
-96.05%21.34M
-96.50%20.51M
-100.21%-1.17M
1,096.77%350.95M
Earning per share
Basic earning per share
-53.85%0.06
140.00%0.24
171.43%0.19
142.86%0.17
--0.13
-91.15%0.1
-95.98%0.07
-96.30%0.07
--0
1,155.56%1.13
Diluted earning per share
-53.85%0.06
140.00%0.24
171.43%0.19
142.86%0.17
--0.13
-91.15%0.1
-95.98%0.07
-96.30%0.07
--0
1,155.56%1.13
Other composite income
Total composite income
-54.52%17.41M
164.45%70.08M
208.73%57.46M
168.92%50.43M
2,204.66%38.29M
-92.42%26.5M
-96.55%18.61M
-96.80%18.75M
-100.32%-1.82M
1,212.94%349.68M
Total composite income of parent company owners
-52.02%18.79M
143.86%73.66M
181.78%60.12M
154.50%52.19M
3,445.73%39.16M
-91.39%30.21M
-96.05%21.34M
-96.50%20.51M
-100.21%-1.17M
1,096.77%350.95M
Total composite income of minority owners
-58.03%-1.38M
3.33%-3.58M
2.24%-2.66M
-0.33%-1.76M
-34.12%-870.29K
-191.14%-3.71M
-282.72%-2.73M
-365.73%-1.75M
-1,052.44%-648.9K
52.69%-1.27M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
ZTE Finance Guanghua Certified Public Accountants (Special General Partnership)
--
--
--
ZTE Finance Guanghua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -27.86%246.82M15.40%1.19B21.08%922.46M26.25%637.23M33.29%342.15M8.73%1.03B7.66%761.89M6.52%504.74M11.52%256.69M-29.36%945.8M
Operating revenue -27.86%246.82M15.40%1.19B21.08%922.46M26.25%637.23M33.29%342.15M8.73%1.03B7.66%761.89M6.52%504.74M11.52%256.69M-29.36%945.8M
Other operating revenue ----68.22%34.09M----77.35%17.57M-----42.77%20.27M-----16.65%9.91M----518.91%35.41M
Total operating cost -24.72%246.97M13.15%1.2B17.08%919.24M21.84%627.69M24.67%328.06M-3.18%1.06B3.17%785.11M0.93%515.17M8.34%263.15M-19.09%1.09B
Operating cost -16.82%105.98M30.31%476.38M29.77%347.21M19.70%222.49M21.96%127.41M18.16%365.57M17.36%267.56M16.69%185.88M25.44%104.47M-37.03%309.38M
Operating tax surcharges -30.70%3.03M-6.05%14.71M-1.63%11.74M4.26%8.33M8.79%4.38M8.52%15.66M9.82%11.94M9.79%7.99M7.53%4.02M-12.68%14.43M
Operating expense -44.01%80.76M-7.07%421.8M2.14%361.87M16.56%266.59M29.84%144.23M-12.30%453.91M0.66%354.29M-0.72%228.72M5.78%111.09M-14.46%517.57M
Administration expense 14.61%39.16M25.35%176.36M34.71%124.78M39.70%82.19M20.32%34.17M-5.91%140.69M-4.52%92.62M-6.65%58.83M2.49%28.4M15.66%149.53M
Financial expense -182.51%-6.66M36.81%-3.98M14.46%-4.12M-5.43%-3.78M-197.64%-2.36M-324.93%-6.29M-294.76%-4.81M-281.71%-3.59M-177.21%-791.9K208.09%2.8M
-Interest expense (Financial expense) 22.63%6.95M1.29%22.89M1.80%16.99M6.82%11.22M36.96%5.66M63.72%22.6M109.80%16.69M93.19%10.5M75.74%4.14M48.00%13.8M
-Interest Income (Financial expense) -24.56%-9.25M4.86%-26.91M-0.89%-20.76M-9.93%-14.27M-40.73%-7.43M-156.56%-28.29M-296.69%-20.58M-336.80%-12.98M-272.75%-5.28M-110.42%-11.03M
Research and development 22.06%24.69M26.37%112.81M22.44%77.76M38.94%51.87M26.71%20.23M-10.66%89.27M-10.18%63.5M-22.98%37.33M-27.84%15.96M-10.80%99.92M
Credit Impairment Loss -108.68%-14.17K490.27%2.78M14.75%848.74K142.46%310.17K136.26%163.18K48.20%-712.57K220.47%739.64K-27.42%-730.58K68.60%-450.04K66.13%-1.38M
Asset Impairment Loss -113.74%-318.31K-84.22%826.15K-81.71%1.03M-133.72%-1.08M-105.22%-148.92K137.72%5.23M421.57%5.61M293.38%3.2M283.72%2.85M-9,709.84%-13.88M
Other net revenue -34.74%19.06M27.16%90.31M21.38%59.52M37.65%46.94M682.83%29.21M-88.22%71.02M-91.88%49.04M-94.63%34.1M-99.35%3.73M1,155.99%602.64M
Fair value change income -48.43%3.68M-3.63%13.37M269.83%10.03M72.60%12.58M175.90%7.15M162.90%13.87M-177.18%-5.91M-86.15%7.29M-224.84%-9.41M115.78%5.28M
Invest income -25.78%8.02M-5.07%43.62M-6.04%34M23.14%24.64M11.82%10.8M-92.32%45.96M-93.85%36.19M-96.54%20.01M-98.30%9.66M4,398.23%598.32M
-Including: Investment income associates -16.28%6.83M-15.47%35.81M-19.67%26.22M-0.26%17.68M5.43%8.15M41.26%42.36M58.27%32.65M52.28%17.72M516.58%7.73M754.39%29.99M
Asset deal income 237.99%172.32K80.42%-2.61M-352.45%-2.6M-662.72%-2.57M56.26%-124.88K-592.94%-13.31M-220.59%-575.62K38.49%-337.59K-380.05%-285.48K56.01%-1.92M
Other revenue -33.86%7.52M61.79%32.31M24.86%16.21M179.43%13.06M730.23%11.38M23.17%19.97M88.77%12.99M-4.64%4.67M-62.97%1.37M-78.78%16.21M
Operating profit -56.32%18.91M94.50%79.02M143.02%62.74M138.58%56.47M1,689.38%43.3M-91.07%40.63M-95.31%25.82M-96.05%23.67M-100.48%-2.72M1,189.70%454.81M
Add:Non operating Income 544.71%215.49K13.57%2.9M-43.55%1.39M148.42%1.38M-93.26%33.42K230.40%2.55M3,323.67%2.46M1,009.76%556.39K2,666.98%495.65K178.72%772.25K
Less:Non operating expense --74.01-82.48%545.16K-54.47%543.72K2,979.20%480.97K----14.30%3.11M149.08%1.19M32.59%15.62K-68.17%3.75K14.16%2.72M
Total profit -55.85%19.13M103.08%81.37M134.77%63.59M136.97%57.37M2,041.09%43.33M-91.15%40.07M-95.07%27.08M-95.96%24.21M-100.40%-2.23M1,265.79%452.86M
Less:Income tax cost -65.95%1.72M-16.76%11.3M-27.69%6.13M27.20%6.94M1,320.41%5.04M-86.85%13.57M-21.49%8.47M-57.96%5.46M-141.70%-412.97K1,481.54%103.18M
Net profit -54.52%17.41M164.45%70.08M208.73%57.46M168.92%50.43MFLtoP38.29M-92.42%26.5M-96.55%18.61M-96.80%18.75MSL-1.82M1,212.94%349.68M
Net profit from continuing operation -54.52%17.41M164.45%70.08M208.73%57.46M168.92%50.43M2,204.66%38.29M-92.42%26.5M-96.55%18.61M-96.80%18.75M-100.32%-1.82M1,212.94%349.68M
Less:Minority Profit -58.03%-1.38M3.33%-3.58M2.24%-2.66M-0.33%-1.76M-34.12%-870.29K-191.14%-3.71M-282.72%-2.73M-365.73%-1.75M-1,052.44%-648.9K52.69%-1.27M
Net profit of parent company owners -52.02%18.79M143.86%73.66M181.78%60.12M154.50%52.19M3,445.73%39.16M-91.39%30.21M-96.05%21.34M-96.50%20.51M-100.21%-1.17M1,096.77%350.95M
Earning per share
Basic earning per share -53.85%0.06140.00%0.24171.43%0.19142.86%0.17--0.13-91.15%0.1-95.98%0.07-96.30%0.07--01,155.56%1.13
Diluted earning per share -53.85%0.06140.00%0.24171.43%0.19142.86%0.17--0.13-91.15%0.1-95.98%0.07-96.30%0.07--01,155.56%1.13
Other composite income
Total composite income -54.52%17.41M164.45%70.08M208.73%57.46M168.92%50.43M2,204.66%38.29M-92.42%26.5M-96.55%18.61M-96.80%18.75M-100.32%-1.82M1,212.94%349.68M
Total composite income of parent company owners -52.02%18.79M143.86%73.66M181.78%60.12M154.50%52.19M3,445.73%39.16M-91.39%30.21M-96.05%21.34M-96.50%20.51M-100.21%-1.17M1,096.77%350.95M
Total composite income of minority owners -58.03%-1.38M3.33%-3.58M2.24%-2.66M-0.33%-1.76M-34.12%-870.29K-191.14%-3.71M-282.72%-2.73M-365.73%-1.75M-1,052.44%-648.9K52.69%-1.27M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --ZTE Finance Guanghua Certified Public Accountants (Special General Partnership)------ZTE Finance Guanghua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg